| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||||
Research and development | ||||||||||
49,381 | 40,653 | 31,976 | 28,976 | 31,423 | 22,697 | 25,230 | 21,034 | 16,633 | 7,725 | 4,567 |
General and administrative | ||||||||||
23,526 | 17,463 | 13,120 | 8,861 | 6,352 | 6,113 | 4,178 | 4,245 | 3,465 | 3,149 | 2,355 |
Total operating expenses | ||||||||||
72,907 | 58,116 | 45,096 | 37,837 | 37,775 | 28,810 | 29,408 | 25,279 | 20,098 | 10,874 | 6,922 |
Loss from operations | ||||||||||
-72,907 | -58,116 | -45,096 | -37,837 | -37,775 | -28,810 | -29,408 | -25,279 | -20,098 | -10,874 | -6,922 |
Change in fair value—preferred stock tranche obligation | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | -813 |
Other income (expense), net | ||||||||||
813 | 1,407 | 2,387 | 2,602 | 1,267 | 1,937 | 1,247 | 827 | -87 | 71 | 11 |
Interest expense | ||||||||||
2,020 | 1,554 | 1,410 | 1,391 | 1,389 | 971 | 937 | 910 | 319 | 2 | 2 |
Net loss | ||||||||||
-74,114 | -58,171 | -44,119 | -36,626 | -37,897 | -27,844 | -29,098 | -25,362 | -20,504 | -10,805 | -7,726 |
Other comprehensive income (loss): | ||||||||||
Net unrealized gain (loss) on available-for-sale investments, net of tax | ||||||||||
-232 | -293 | -143 | 480 | 302 | -113 | -14 | 41 | -54 | 8 | -9 |
Total comprehensive loss | ||||||||||
-74,346 | -58,464 | -44,262 | -36,146 | -37,595 | -27,957 | -29,112 | -25,321 | -20,558 | -10,797 | -7,735 |
Net loss per share, basic and diluted (in USD per share) | ||||||||||
-1.49 | -1.18 | -0.89 | -0.75 | -0.90 | 15.96 | -0.71 | -10.89 | -9.00 | -4.81 | -3.60 |
Weighted-average number of shares outstanding, basic and diluted (in shares) | ||||||||||
49,841 | 49,724 | 49,418 | 48,674 | 42,268 | 42,715 | 41,261 | 2,329 | 2,278 | 2,244 | 2,145 |